Ποια είναι η τιμή για Guerbet S.A. (GBT)

Η τιμή για Guerbet S.A. (GBT) είναι $9.37

Ποια είναι η κεφαλαιοποίηση αγοράς για Guerbet S.A. (GBT)

Η κεφαλαιοποίηση αγοράς για Guerbet S.A. (GBT) είναι $118.21M

Guerbet S.A. (GBT) Τιμή και Κεφαλαιοποίηση Αγοράς

Guerbet SA is dedicated to the development and commercialization of a broad spectrum of contrast media, advanced delivery systems, medical devices, and related solutions for diagnostic imaging. Their extensive product lineup features iodinated contrast agents such as Optiray and Xenetix, both non-ionic monomeric; Telebrix Gastro, a meglumine ioxitalamate solution; and Conray, an iothalamate meglumine injection. They also offer Micropaque/Microtrast, an integrated diagnostic imaging solution. For MRI applications, the company provides gadoteric acid-based contrast agents like Dotarem (gadoterate meglumine) and Artirem. Complementing these are essential delivery systems and consumables, including prefilled syringes, injectors, and accessories designed for use in MRI, CT, and Cath Lab settings. Guerbet also delivers innovative digital health solutions such as Contrast&Care for injection management, Dose&Care for X-ray dose management, and icobrain, a cloud-based AI platform that quantifies disease-specific brain structures from MR and CT scans for acute and chronic neurological conditions. Additionally, they offer OptiProtect services. In the realm of interventional radiology, the company provides products like Lipiodol (ethyl esters of iodinated fatty acids of poppyseed oil), Vectorio (a mixing and injection system for conventional trans-arterial chemoembolization), Patent Blue V (a blue dye), Axessio (a peripheral micro guidewire), and microcatheters such as SeQure and DraKon. Furthermore, their offerings include Hydra Vision, a digital imaging system tailored for urological, gastroenterological, and gynecological treatment, planning, and diagnostic procedures, alongside various urology accessories and consumables. Established in 1926, Guerbet's headquarters are situated in Villepinte, France.

Η τιμή για GBT	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$413,107 $118.21M	NVDA	$5.211T	+4,408,432.79%
$360,422 $118.21M	AAPL	$4.547T	+3,846,198.20%
$329,961 $118.21M	GOOG	$4.162T	+3,521,126.80%
$284,802 $118.21M	MSFT	$3.593T	+3,039,204.27%
$221,391 $118.21M	AMZN	$2.793T	+2,362,501.86%

Η τιμή για GBT

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$413,107 $118.21M